关注
Sho Iketani
Sho Iketani
Columbia University Medical Center
在 cumc.columbia.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7
P Wang, MS Nair, L Liu, S Iketani, Y Luo, Y Guo, M Wang, J Yu, B Zhang, ...
Nature 593 (7857), 130-135, 2021
22892021
Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2
L Liu, S Iketani, Y Guo, JFW Chan, M Wang, L Liu, Y Luo, H Chu, Y Huang, ...
Nature 602 (7898), 676-681, 2022
11912022
Antibody evasion properties of SARS-CoV-2 Omicron sublineages
S Iketani, L Liu, Y Guo, L Liu, JFW Chan, Y Huang, M Wang, Y Luo, J Yu, ...
Nature 604 (7906), 553-556, 2022
7752022
Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4, & BA.5
Q Wang, Y Guo, S Iketani, MS Nair, Z Li, H Mohri, M Wang, J Yu, ...
Nature 608 (7923), 603-608, 2022
6872022
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants
Q Wang, S Iketani, Z Li, L Liu, Y Guo, Y Huang, AD Bowen, M Liu, ...
Cell 186 (2), 279-286, 2023
5952023
Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir
S Iketani, H Mohri, B Culbertson, SJ Hong, Y Duan, MI Luck, ...
Nature 613 (7944), 558-564, 2023
2042023
Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors
S Iketani, F Forouhar, H Liu, SJ Hong, FY Lin, MS Nair, A Zask, Y Huang, ...
Nature Communications 12 (1), 1-7, 2021
1002021
Antigenic characterization of the SARS-CoV-2 Omicron subvariant BA.2.75
Q Wang, S Iketani, Z Li, Y Guo, AY Yeh, M Liu, J Yu, Z Sheng, Y Huang, ...
Cell Host & Microbe 30 (11), 1512-1517, 2022
822022
Antigenicity and receptor affinity of SARS-CoV-2 BA.2.86 spike
Q Wang, Y Guo, L Liu, LT Schwanz, Z Li, MS Nair, J Ho, RM Zhang, ...
Nature 624 (7992), 639-644, 2023
792023
Influenza virus uses transportin 1 for vRNP debundling during cell entry
Y Miyake, JJ Keusch, L Decamps, H Ho-Xuan, S Iketani, H Gut, U Kutay, ...
Nature Microbiology 4 (4), 578-586, 2019
602019
Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19
H Liu, S Iketani, A Zask, N Khanizeman, E Bednarova, F Forouhar, ...
Nature Communications 13 (1), 1-16, 2022
572022
Complex and dynamic interactions between parvovirus capsids, transferrin receptors, and antibodies control cell infection and host range
HM Callaway, K Welsch, W Weichert, AB Allison, SL Hafenstein, K Huang, ...
Journal of Virology 92 (13), e00460-18, 2018
412018
CRISPR-based gene knockout screens reveal deubiquitinases involved in HIV-1 latency in two Jurkat cell models
A Rathore, S Iketani, P Wang, M Jia, V Sahi, DD Ho
Scientific Reports 10 (1), 1-14, 2020
392020
A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses
P Wang, RG Casner, MS Nair, J Yu, Y Guo, M Wang, JFW Chan, G Cerutti, ...
Emerging Microbes & Infections 11 (1), 147-157, 2022
372022
Molecular mechanisms of SARS-CoV-2 resistance to nirmatrelvir
Y Duan, H Zhou, X Liu, S Iketani, M Lin, X Zhang, Q Bian, H Wang, H Sun, ...
Nature 622 (7982), 376-382, 2023
342023
An antibody class with a common CDRH3 motif broadly neutralizes sarbecoviruses
L Liu, S Iketani, Y Guo, ER Reddem, RG Casner, MS Nair, J Yu, ...
Science Translational Medicine 14 (646), eabn6859, 2022
342022
Near-atomic resolution structure of a highly neutralizing Fab bound to canine parvovirus
LJ Organtini, H Lee, S Iketani, K Huang, RE Ashley, AM Makhov, ...
Journal of Virology 90 (21), 9733-9742, 2016
332016
Functional map of SARS-CoV-2 3CL protease reveals tolerant and immutable sites
S Iketani, SJ Hong, J Sheng, F Bahari, B Culbertson, FF Atanaki, ...
Cell Host & Microbe 30 (10), 1354-1362, 2022
32*2022
Inhibitors of Coronavirus 3CL proteases protect cells from protease-mediated cytotoxicity
SJ Resnick, S Iketani, SJ Hong, A Zask, H Liu, S Kim, S Melore, FY Lin, ...
Journal of Virology 95 (14), e02374-20, 2021
312021
Viral Entry Properties Required for Fitness in Humans Are Lost through Rapid Genomic Change during Viral Isolation
S Iketani, RC Shean, M Ferren, N Makhsous, DB Aquino, A des Georges, ...
mBio 9 (4), e00898-18, 2018
282018
系统目前无法执行此操作,请稍后再试。
文章 1–20